- Home
- ICLR vs BALL Comparison
ICLR vs BALL Comparison
Compare ICLR & BALL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ICLR
- BALL
- Stock Information
- Founded
- ICLR 1990
- BALL 1880
- Country
- ICLR Ireland
- BALL United States
- Employees
- ICLR 41100
- BALL N/A
- Industry
- ICLR Biotechnology: Commercial Physical & Biological Resarch
- BALL Containers/Packaging
- Sector
- ICLR Health Care
- BALL Industrials
- Exchange
- ICLR Nasdaq
- BALL Nasdaq
- Market Cap
- ICLR 24.3B
- BALL 20.5B
- IPO Year
- ICLR 1998
- BALL N/A
- Fundamental
- Price
- ICLR $293.54
- BALL $65.65
- Analyst Decision
- ICLR Strong Buy
- BALL Hold
- Analyst Count
- ICLR 10
- BALL 13
- Target Price
- ICLR $351.60
- BALL $70.00
- AVG Volume (30 Days)
- ICLR 824.8K
- BALL 1.4M
- Earning Date
- ICLR 10-23-2024
- BALL 10-31-2024
- Dividend Yield
- ICLR N/A
- BALL 1.21%
- EPS Growth
- ICLR 39.27
- BALL 427.08
- EPS
- ICLR 8.61
- BALL 13.29
- Revenue
- ICLR $8,331,892,000.00
- BALL $13,814,000,000.00
- Revenue This Year
- ICLR $6.84
- BALL N/A
- Revenue Next Year
- ICLR $8.10
- BALL $3.60
- P/E Ratio
- ICLR $34.07
- BALL $4.96
- Revenue Growth
- ICLR 5.42
- BALL 1.97
- 52 Week Low
- ICLR $221.20
- BALL $42.81
- 52 Week High
- ICLR $347.72
- BALL $71.32
- Technical
- Relative Strength Index (RSI)
- ICLR 45.56
- BALL 49.57
- Support Level
- ICLR $280.96
- BALL $65.27
- Resistance Level
- ICLR $305.14
- BALL $68.12
- Average True Range (ATR)
- ICLR 8.88
- BALL 0.94
- MACD
- ICLR 0.83
- BALL -0.23
- Stochastic Oscillator
- ICLR 42.53
- BALL 18.95
About ICLR ICON plc
Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.
About BALL Ball Corporation
Ball is the world's largest metal can manufacturer with market share over 40% in its three main regions (North America, Europe, and South America). The company is focused on increasing capacity amid a wave of new developed-market demand, while also investing in faster-growing emerging-market economies. Ball maintains a small presence in the U.S. defense industry through its aerospace segment. Ball spun-off its glass jar business in 1993 and is now owned by Newell. The company reports three segments—beverage packaging, North and Central America (43% of 2023 revenue), beverage packaging, EMEA (24%), beverage packaging, South America (14%)—and it generated $14 billion in revenue in 2023.